May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Characterisation of Pre–Teceptor Glucocorticoid Regulation in the Rabbit Eye
Author Affiliations & Notes
  • C. Onyimba
    Birmingham University, Birmingham, United Kingdom
    Endocrinology, Division of Medical Sciences,
  • N. Vijapurapu
    Birmingham University, Birmingham, United Kingdom
    Endocrinology, Division of Medical Sciences,
  • J. Curnow
    Birmingham University, Birmingham, United Kingdom
    Ophthalmology, Division of Immunity and Infection,
  • I.J. Bujalska
    Birmingham University, Birmingham, United Kingdom
    Endocrinology, Division of Medical Sciences,
  • S.V. Hughes
    Birmingham University, Birmingham, United Kingdom
    Endocrinology, Division of Medical Sciences,
  • P. Khosla
    Birmingham University, Birmingham, United Kingdom
    Endocrinology, Division of Medical Sciences,
  • P.M. Stewart
    Birmingham University, Birmingham, United Kingdom
    Endocrinology, Division of Medical Sciences,
  • P.I. Murray
    Birmingham University, Birmingham, United Kingdom
    Ophthalmology, Division of Immunity and Infection,
  • E.A. Walker
    Birmingham University, Birmingham, United Kingdom
    Endocrinology, Division of Medical Sciences,
  • S. Rauz
    Birmingham University, Birmingham, United Kingdom
    Ophthalmology, Division of Immunity and Infection,
  • Footnotes
    Commercial Relationships  C. Onyimba, None; N. Vijapurapu, None; J. Curnow, None; I.J. Bujalska, None; S.V. Hughes, None; P. Khosla, None; P.M. Stewart, None; P.I. Murray, None; E.A. Walker, None; S. Rauz, None.
  • Footnotes
    Support  Wellcome Trust, UK; Pfizer Research Grant
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5431. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. Onyimba, N. Vijapurapu, J. Curnow, I.J. Bujalska, S.V. Hughes, P. Khosla, P.M. Stewart, P.I. Murray, E.A. Walker, S. Rauz; Characterisation of Pre–Teceptor Glucocorticoid Regulation in the Rabbit Eye . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5431.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Glucocorticoids (GCs) activate receptors that translocate from the cytoplasm to the nuclear chromatin thereby modulating transcription of specific GC responsive genes. The preceptor regulation of GCs has emerged as a novel determinant of GC function in systemic tissues such as adipose and bone, but is less well described in the eye. Regulation is dependent on the expression of a bidirectional isozyme, 11ß–hydroxysteroid dehydrogenase (11ß–HSD1) that interconverts active cortisol and inactive cortisone. Recent descriptive studies have localised this isozyme to the human corneal epithelium and non–pigmented epithelium of the ciliary body. In this study we characterise preceptor regulation of GCs in an animal model – the New Zealand White Albino rabbit (NZWAR).

Methods: : Using in–house generated primary antibody to human 11ß–HSD1, immunohistochemical analyses were performed on paraffin embedded sections of whole NZWAR eyes. 11ß–HSD1 enzyme assays for oxo–reductase (cortisone to cortisol) and dehydrogenase (cortisol to cortisone) activity were conducted on NZWAR primary cultures (corneal stromal keratocytes (CSK), corneal epithelium (CEC), conjunctival fibroblasts (CF)) and dissected ciliary body tissue (CBT). Further examination of 11ß–HSD1 expression was undertaken using immunocytochemistry of CEC and Western Blot analyses of CBT.

Results: : Immunohistochemical studies showed that 11ß–HSD1 localised to the corneal epithelium and NPE of the ciliary body. Specific activity assays indicated predominant 11ß–HSD1 oxo–reductase activity from both the CBT (n=12, median, 44.4% conversion; range, 26.9–61.7%; p=0.003) and CEC (median, 3.0±1.9 pmol/mg/ml, p=0.006) compared to dehydrogenase activity (median, 18.6% conversion; range, 10.9–44.9% and 0.5±0.8 pmol/mg/ml respectively). These findings were supported by expression of the 11ß–HSD1 protein as visualised by Western Blotting of CBT and immunocytochemistry of CEC. 11ß–HSD1 activity was not demonstrated in basal CF or CSK.

Conclusions: : Our results indicate that pre–receptor GC regulation by 11ß–HSD1 is a component of GC function in rabbit corneal and uveal tissues. 11ß–HSD1 manipulation may represent a novel therapeutic mechanism for GC responsive eye disease.

Keywords: corticosteroids • cornea: epithelium • enzymes/enzyme inhibitors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×